Literature DB >> 29124316

Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease.

Carlo Tascini1, Fiorentino Fraganza2, Francesca Salani3, Emanuela Sozio4, Marco Rossi1, Francesco Sbrana5, Novella Carannante1, Maria Daniela Chiesa2, Andrea Ripoli5, Giacomo Bertolino6, Massimo Di Pietro7, Alessandro Bartoloni8,9, Francesco Menichetti10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29124316     DOI： 10.1007/s00134-017-4957-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

Review 1.  Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness.

Authors:  Stefano Busani; Elisa Damiani; Ilaria Cavazzuti; Abele Donati; Massimo Girardis
Journal:  Minerva Anestesiol       Date:  2015-10-16       Impact factor: 3.051

2.  Meningococcal carriage in a population of "normal" families.

Authors:  S Greenfield; P R Sheehe; H A Feldman
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

3.  Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.

Authors:  N D Garbett; C S Munro; P J Cole
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

4.  THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS.

Authors:  S Flexner
Journal:  J Exp Med       Date:  1913-05-01       Impact factor: 14.307
  4 in total
  1 in total

Review 1.  Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis.

Authors:  Axel Nierhaus; Giorgio Berlot; Detlef Kindgen-Milles; Eckhard Müller; Massimo Girardis
Journal:  Ann Intensive Care       Date:  2020-10-07       Impact factor: 6.925
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.